Pieris Days Of Sales Outstanding from 2010 to 2024
| PIRS Stock | USD 11.72 0.12 1.03% |
Days Of Sales Outstanding | First Reported 2010-12-31 | Previous Quarter 51.48878767 | Current Value 42.39 | Quarterly Volatility 54.8676727 |
Check Pieris Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pieris main balance sheet or income statement drivers, such as Interest Expense of 12.3 M, Selling General Administrative of 13.5 M or Other Operating Expenses of 46.1 M, as well as many exotic indicators such as Price To Sales Ratio of 0.36, Dividend Yield of 0.0 or PTB Ratio of 0.58. Pieris financial statements analysis is a perfect complement when working with Pieris Pharmaceuticals Valuation or Volatility modules.
Pieris | Days Of Sales Outstanding |
Latest Pieris Pharmaceuticals' Days Of Sales Outstanding Growth Pattern
Below is the plot of the Days Of Sales Outstanding of Pieris Pharmaceuticals over the last few years. It is Pieris Pharmaceuticals' Days Of Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pieris Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Days Of Sales Outstanding | 10 Years Trend |
|
Days Of Sales Outstanding |
| Timeline |
Pieris Days Of Sales Outstanding Regression Statistics
| Arithmetic Mean | 42.44 | |
| Geometric Mean | 21.94 | |
| Coefficient Of Variation | 129.28 | |
| Mean Deviation | 32.22 | |
| Median | 21.24 | |
| Standard Deviation | 54.87 | |
| Sample Variance | 3,010 | |
| Range | 223 | |
| R-Value | 0.27 | |
| Mean Square Error | 3,012 | |
| R-Squared | 0.07 | |
| Significance | 0.34 | |
| Slope | 3.26 | |
| Total Sum of Squares | 42,146 |
Pieris Days Of Sales Outstanding History
About Pieris Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Pieris Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Pieris Pharmaceuticals investors use historical funamental indicators, such as Pieris Pharmaceuticals's Days Of Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Pieris Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Pieris Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pieris Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pieris Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pieris Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Sales Outstanding | 51.49 | 42.39 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pieris Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pieris Pharmaceuticals' short interest history, or implied volatility extrapolated from Pieris Pharmaceuticals options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pieris Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Pieris Pharmaceuticals Correlation against competitors. For more information on how to buy Pieris Stock please use our How to Invest in Pieris Pharmaceuticals guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Pieris Stock analysis
When running Pieris Pharmaceuticals' price analysis, check to measure Pieris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pieris Pharmaceuticals is operating at the current time. Most of Pieris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pieris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pieris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pieris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Pieris Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pieris Pharmaceuticals. If investors know Pieris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pieris Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (21.60) | Revenue Per Share 38.026 | Quarterly Revenue Growth (0.78) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Pieris Pharmaceuticals is measured differently than its book value, which is the value of Pieris that is recorded on the company's balance sheet. Investors also form their own opinion of Pieris Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Pieris Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pieris Pharmaceuticals' market value can be influenced by many factors that don't directly affect Pieris Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pieris Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pieris Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pieris Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.